Seroconversion in Pacients After SARS-Cov-2 CHADOX1 NCoV-19/AZD1222 Vaccination in Hemodialysis Patients And Kidney Transplant Recipients

被引:0
|
作者
Chew-Wong, Alfredo [1 ]
Morales-Lopez, Lizbeth [1 ]
Hernandez-Infante, Elizabeth [1 ]
Guerra, Jose M. Arreola [1 ]
Ricalde-Rios, Guadalupe [1 ]
Roque-Flores, Roberto [1 ]
Romo-Franco, Luis [1 ]
Gonzalez-Gamez, Mario [1 ]
Lagunas-Rodriguez, Ana B. [1 ]
Reyes-Acevedo, Rafael [1 ]
机构
[1] Centenario Hosp Miguel Hidalgo, Nephrol & Kidney Transplantat, Aguascalientes, Mexico
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P16.06
引用
收藏
页码:S726 / S727
页数:2
相关论文
共 50 条
  • [31] AZ arm: Delayed cutaneous reaction to ChAdOx1 nCoV-19 (AZD1222) vaccine
    Wei-Kai, Hung
    Chi, Ching-Chi
    Wang, Shu-Hui
    DERMATOLOGICA SINICA, 2022, 40 (01) : 52 - 53
  • [32] AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice
    Stebbings, Richard
    Armour, Gillian
    Pettis, Vivian
    Goodman, Joanne
    VACCINE, 2022, 40 (02) : 192 - 195
  • [33] Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
    Cohen, Guy
    Jungsomsri, Pawornrath
    Sangwongwanich, Jirath
    Tawinprai, Kriangkrai
    Siripongboonsitti, Taweegrit
    Porntharukchareon, Thachanun
    Wittayasak, Kasiruck
    Thonwirak, Nawarat
    Soonklang, Kamonwan
    Sornsamdang, Gaidganok
    Auewarakul, Chirayu
    Mahanonda, Nithi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [34] Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle
    Choi, Hyunji
    Lee, Sun-Min
    Lim, Seungjin
    Shin, Kyung-Hwa
    Kim, Taeyun
    Kim, Won-joo
    Yun, Misook
    Oh, Seung-Hwan
    VACCINES, 2021, 9 (12)
  • [35] An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
    Marchevsky, Natalie Gabrielle
    Li, Grace
    Aley, Parvinder
    Clemens, Sue Ann Costa
    Barrett, Jordan Richard
    Belij-Rammerstorfer, Sandra
    Bibi, Sagida
    Clutterbuck, Elizabeth
    Dold, Christina
    Felle, Sally
    Flaxman, Amy
    Folegatti, Pedro
    Jenkin, Daniel
    Gilbert, Sarah
    Kelly, Sarah
    Lambe, Teresa
    Plested, Emma
    Ramasamy, Maheshi
    Singh, Nisha
    Smith, Holly
    Taylor, Stephen
    Weckx, Lily
    Pollard, Andrew John
    Voysey, Merryn
    EBIOMEDICINE, 2022, 81
  • [36] Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine
    Vimonsri Rangsrisaeneepitak
    Thachanun Porntharukchareon
    Bothamai Dechates
    Supamas Sirisreetreerux
    Kriangkrai Tawinprai
    Diabetology International, 2022, 13 : 637 - 643
  • [37] Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers
    Lim, Sera
    Lee, Yuil
    Kim, Dong Wan
    Park, Won Sang
    Yoon, Jung Hwan
    Lee, Jung Young
    INFECTION AND CHEMOTHERAPY, 2022, 54 (01): : 140 - 152
  • [38] Profile of Humoral Immunity and B Cell Pool in Infection with the SARS-CoV-2 Prototype Strain and AZD1222 (ChAdOx nCoV-19) Vaccination
    Familiar-Macedo, Debora
    de Azeredo, Elzinandes Leal
    de Lemos, Elba Regina Sampaio
    Damasco, Paulo Vieira
    de-Oliveira-Pinto, Luzia Maria
    VACCINES, 2025, 13 (02)
  • [39] Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine
    Rangsrisaeneepitak, Vimonsri
    Porntharukchareon, Thachanun
    Dechates, Bothamai
    Sirisreetreerux, Supamas
    Tawinprai, Kriangkrai
    DIABETOLOGY INTERNATIONAL, 2022, 13 (04) : 637 - 643
  • [40] Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital
    Limpawittayakul, Piyarat
    Sungkasubun, Prakongboon
    Chaiwiriyawong, Worawit
    Supavavej, Archara
    Weerasubpong, Bowon
    Siripaibun, Jomtana
    Phanthunane, Chumut
    Lamlertthon, Wisut
    Ungtrakul, Teerapat
    Tawinprai, Kriangkrai
    Tantiyavarong, Walaipan
    Samdaengpan, Chayanee
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)